Accounts Receivable, after Allowance for Credit Loss, Current of SI-BONE, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
SI-BONE, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • SI-BONE, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2025 was $29,915,000, a 8.9% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

SI-BONE, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $29,915,000 +$2,456,000 +8.9% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $26,534,000 +$1,625,000 +6.5% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $24,371,000 -$425,000 -1.7% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $26,705,000 +$4,596,000 +21% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $27,459,000 +$5,506,000 +25% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $24,909,000 +$4,921,000 +25% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $24,796,000 +$4,374,000 +21% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $22,109,000 -$491,000 -2.2% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $21,953,000 +$1,279,000 +6.2% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $19,988,000 +$3,535,000 +21% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $20,422,000 +$5,304,000 +35% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $22,600,000 +$9,918,000 +78% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $20,674,000 +$6,428,000 +45% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $16,453,000 +$3,836,000 +30% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $15,118,000 +$3,224,000 +27% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $12,682,000 -$406,000 -3.1% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $14,246,000 +$635,000 +4.7% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $12,617,000 +$1,200,000 +11% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $11,894,000 +$1,634,000 +16% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $13,088,000 +$3,727,000 +40% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $13,611,000 +$1,891,000 +16% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $11,417,000 +$1,499,000 +15% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $10,260,000 +$856,000 +9.1% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $9,361,000 +$950,000 +11% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $11,720,000 +$3,234,000 +38% 31 Dec 2019 10-K 10 Mar 2021 2020 FY
Q3 2019 $9,918,000 +$2,826,000 +40% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $9,404,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $8,411,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $8,486,000 +$1,070,000 +14% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q3 2018 $7,092,000 30 Sep 2018 10-Q 29 Nov 2018 2018 Q3
Q4 2017 $7,416,000 31 Dec 2017 10-K 14 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.